Medipal Holdings Corp 7459
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 2,449.50
- Day Range
- JPY 2,425.50–2,472.00
- 52-Week Range
- JPY 2,119.00–2,683.50
- Bid/Ask
- JPY 2,432.00 / JPY 2,433.00
- Market Cap
- JPY 510.66 Bil
- Volume/Avg
- 198,700 / 597,582
Key Statistics
- Price/Earnings (Normalized)
- 14.39
- Price/Sales
- 0.15
- Dividend Yield (Trailing)
- 2.45%
- Dividend Yield (Forward)
- 2.45%
- Total Yield
- 3.61%
Company Profile
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Value
- Total Number of Employees
- 21,224
- Website
- http://www.medipal.co.jp
Comparables
Valuation
|
Metric
|
7459
|
7649
|
3141
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.39 | 5.77 | 15.53 |
Price/Book Value | 0.89 | 1.86 | 2.00 |
Price/Sales | 0.15 | 0.58 | 0.39 |
Price/Cash Flow | 8.60 | 10.89 | 9.05 |
Price/Earnings
7459
7649
3141
Financial Strength
|
Metric
|
7459
|
7649
|
3141
|
|---|---|---|---|
Quick Ratio | 0.93 | 0.74 | 0.41 |
Current Ratio | 1.20 | 1.46 | 1.12 |
Interest Coverage | 3,355.30 | — | 63.37 |
Quick Ratio
7459
7649
3141
Profitability
|
Metric
|
7459
|
7649
|
3141
|
|---|---|---|---|
Return on Assets (Normalized) | 3.64% | 10.12% | 9.15% |
Return on Equity (Normalized) | 11.45% | 16.84% | 22.16% |
Return on Invested Capital (Normalized) | 8.99% | 16.84% | 15.69% |
Return on Assets
7459
7649
3141
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Ysgnskkr | Nqcgyjj | $72.1 Bil | |
COR
| Cencora Inc | Bjtcpxyy | Wllzscs | $44.7 Bil | |
CAH
| Cardinal Health Inc | Drzqdqlv | Gshngj | $23.9 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Kppltwm | $8.9 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Mbqmw | $8.4 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Lsqlhl | $8.4 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Hgmpmq | $8.3 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Ydlbgyd | $8.3 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Yssgm | $3.3 Bil | |
MEPDF
| Medipal Holdings Corp | — | Xdjm | $3.3 Bil |